, /PRNewswire/ -- The global immunohematology market size is estimated to grow by from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 7.35% during the forecast period.
Shift by end-users to automated immunohematology analyzers is driving market growth, with a trend towards paradigm shift toward molecular immunohematology. However, high maintenance cost and low reimbursement for blood components poses a challenge. Key market players include and Co.
, Biomed Global, Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Calibre Scientific Inc.
, Danaher Corp., DIAGAST SAS, Grifols SA, Hemo bioscience Inc., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Institut de Biotechnologies Jacques Boy, MAK SYSTEM S.
A., Merck KGaA, Mesa Laboratories Inc., Quotient Ltd.
, Siemens AG, Thermo Fisher Scientific Inc., Tulip Diagnostics Pvt. Ltd.
, and Werfenlife SA. Get a detailed analysis on regions, market segments, customer landscape, and companies - Molecular analysis plays a crucial role in the detection of antigen molecular and genetic structures, enhancing clinicians' understanding of blood group antigens and blood typing. This method is now a standard practice before unrelated donor blood transfusions due to cross-matching requirements.
The adoption of molecular immunohematology, alongside serological and HLA typing, is on the rise in blood banks and hospitals. This shift towards advanced molecular techniques is expected to fuel the growth o.
